{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:10:47Z","timestamp":1788685847266,"version":"build-2803163510"},"reference-count":99,"publisher":"The Company of Biologists","issue":"10","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Breast Cancer Now"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C33043"],"award-info":[{"award-number":["C33043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["A24478"],"award-info":[{"award-number":["A24478"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Cancer Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Amoeboid behaviour represents a distinct and clinically significant cancer cell state within the epithelial-to-mesenchymal transition (EMT) spectrum. Defined by the loss of cell\u2013cell junctions and adoption of a rounded morphology, amoeboid cancer cells exhibit low adhesion and rely heavily on Rho\u2013ROCK\u2013myosin II-mediated cortical contractility. This combination of high contractility and reduced adhesion enables rapid migration through dense, confining environments, using blebs as functional protrusions. This behaviour is commonly observed at tumour invasive fronts, within metastatic deposits and among therapy-resistant cell populations. Amoeboid identity integrates multiple biochemical signalling programmes alongside mechanical cues such as confinement, matrix topography and shear stress. Collectively, these factors drive a highly plastic state characterised by stem-cell-like traits, metabolic adaptability, low oxidative stress and an immunosuppressive secretome. Such features confer strong metastatic potential and broad resistance to therapy, underpinned by core physicochemical dependencies on cortical tension, membrane mechanics and redox balance. This Cell Science at a Glance article and the accompanying poster highlight these defining characteristics, establishing amoeboid behaviour as a crucial driver of cancer progression and an increasingly promising therapeutic target.<\/jats:p>","DOI":"10.1242\/jcs.264674","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:30:56Z","timestamp":1780047056000},"source":"Crossref","is-referenced-by-count":2,"title":["Amoeboid cancer cells at a glance"],"prefix":"10.1242","volume":"139","author":[{"given":"Ritobrata","family":"Ghose","sequence":"first","affiliation":[{"name":"The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research Cytoskeleton and Cancer Metastasis Laboratory , , London SW3 6JB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-9456","authenticated-orcid":false,"given":"Victoria","family":"Sanz-Moreno","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research Cytoskeleton and Cancer Metastasis Laboratory , , London SW3 6JB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026052905305082300_JCS264674C1","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1091\/mbc.E21-04-0174","article-title":"Survey of cancer cell anatomy in nonadhesive confinement reveals a role for filamin-A and fascin-1 in leader bleb-based migration","volume":"32","author":"Adams","year":"2021","journal-title":"Mol. Biol. Cell"},{"key":"2026052905305082300_JCS264674C2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2026052905305082300_JCS264674C3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-020-20826-5","article-title":"STIM-Orai1 signaling regulates fluidity of cytoplasm during membrane blebbing","volume":"12","author":"Aoki","year":"2021","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"2026052905305082300_JCS264674C5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"2026052905305082300_JCS264674C6","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.18632\/oncotarget.27341","article-title":"The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo","volume":"10","author":"Blum","year":"2019","journal-title":"Oncotarget"},{"key":"2026052905305082300_JCS264674C7","doi-asserted-by":"publisher","first-page":"100530","DOI":"10.1016\/j.esmoop.2022.100530","article-title":"Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors","volume":"7","author":"Borazanci","year":"2022","journal-title":"ESMO Open"},{"key":"2026052905305082300_JCS264674C8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/bjc.2014.99","article-title":"Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer","volume":"110","author":"Brown","year":"2014","journal-title":"Br. J. Cancer"},{"key":"2026052905305082300_JCS264674C9","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cub.2015.09.054","article-title":"TGF-\u03b2-induced transcription sustains amoeboid melanoma migration and dissemination","volume":"25","author":"Cantelli","year":"2015","journal-title":"Curr. Biol."},{"key":"2026052905305082300_JCS264674C10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2818.2008.02059.x","article-title":"A short history of blebbing","volume":"231","author":"Charras","year":"2008","journal-title":"J. Microsc."},{"key":"2026052905305082300_JCS264674C11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature03550","article-title":"Non-equilibration of hydrostatic pressure in blebbing cells","volume":"435","author":"Charras","year":"2005","journal-title":"Nature"},{"key":"2026052905305082300_JCS264674C12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1083\/jcb.200602085","article-title":"Reassembly of contractile actin cortex in cell blebs","volume":"175","author":"Charras","year":"2006","journal-title":"J. Cell Biol."},{"key":"2026052905305082300_JCS264674C13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.rdc.2004.01.005","article-title":"The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis","volume":"30","author":"Cohen","year":"2004","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"2026052905305082300_JCS264674C14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1038\/onc.2016.454","article-title":"The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination","volume":"36","author":"Crosas-Molist","year":"2017","journal-title":"Oncogene"},{"key":"2026052905305082300_JCS264674C15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","article-title":"RHO GTPase signaling in cancer progression and dissemination","volume":"102","author":"Crosas-Molist","year":"2022","journal-title":"Physiol. Rev."},{"key":"2026052905305082300_JCS264674C16","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1038\/s41467-023-38292-0","article-title":"AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration","volume":"14","author":"Crosas-Molist","year":"2023","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C17","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"2026052905305082300_JCS264674C18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ijo.2012.1672","article-title":"BML-275, an AMPK inhibitor, induces DNA damage, G2\/M arrest and apoptosis in human pancreatic cancer cells","volume":"41","author":"Duong","year":"2012","journal-title":"Int. J. Oncol."},{"key":"2026052905305082300_JCS264674C19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s42003-019-0514-3","article-title":"Myosin-II mediated traction forces evoke localized Piezo1-dependent Ca2+ flickers","volume":"2","author":"Ellefsen","year":"2019","journal-title":"Commun. Biol."},{"key":"2026052905305082300_JCS264674C20","doi-asserted-by":"publisher","first-page":"e201912159","DOI":"10.1083\/jcb.201912159","article-title":"CDC42EP5\/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion","volume":"219","author":"Farrugia","year":"2020","journal-title":"J. Cell Biol."},{"key":"2026052905305082300_JCS264674C21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1089\/neu.2011.1765","article-title":"A phase I\/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury","volume":"28","author":"Fehlings","year":"2011","journal-title":"J. Neurotrauma"},{"key":"2026052905305082300_JCS264674C22","doi-asserted-by":"publisher","first-page":"eadx2434","DOI":"10.1126\/sciadv.adx2434","article-title":"Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827","volume":"11","author":"Fraguas Bringas","year":"2025","journal-title":"Sci. Adv."},{"key":"2026052905305082300_JCS264674C23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.200909003","article-title":"Plasticity of cell migration: a multiscale tuning model","volume":"188","author":"Friedl","year":"2010","journal-title":"J. Cell Biol."},{"key":"2026052905305082300_JCS264674C24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.cub.2008.08.053","article-title":"DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells","volume":"18","author":"Gadea","year":"2008","journal-title":"Curr. Biol."},{"key":"2026052905305082300_JCS264674C25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.tcb.2024.02.009","article-title":"Blebology: principles of bleb-based migration","volume":"34","author":"Garc\u00eda-Arcos","year":"2024","journal-title":"Trends Cell Biol."},{"key":"2026052905305082300_JCS264674C26","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.devcel.2024.06.023","article-title":"Rigidity percolation and active advection synergize in the actomyosin cortex to drive amoeboid cell motility","volume":"59","author":"Garc\u00eda-Arcos","year":"2024","journal-title":"Dev. Cell"},{"key":"2026052905305082300_JCS264674C27","doi-asserted-by":"publisher","first-page":"1091801","DOI":"10.3389\/fcell.2022.1091801","article-title":"Amoeboid migration in health and disease: Immune responses versus cancer dissemination","volume":"10","author":"George","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"2026052905305082300_JCS264674C28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2018.12.038","article-title":"Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment","volume":"176","author":"Georgouli","year":"2019","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C29","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1038\/s41467-025-61787-x","article-title":"Mitochondria-derived nuclear ATP surge protects against confinement-induced proliferation defects","volume":"16","author":"Ghose","year":"2025","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bpj.2016.11.013","article-title":"GsMTx4: mechanism of inhibiting mechanosensitive ion channels","volume":"112","author":"Gnanasambandam","year":"2017","journal-title":"Biophys. J."},{"key":"2026052905305082300_JCS264674C31","doi-asserted-by":"publisher","first-page":"EMBJ201898994","DOI":"10.15252\/embj.201898994","article-title":"KIF 13A-regulated RhoB plasma membrane localization governs membrane blebbing and blebby amoeboid cell migration","volume":"37","author":"Gong","year":"2018","journal-title":"EMBO J."},{"key":"2026052905305082300_JCS264674C32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tcb.2021.10.004","article-title":"The amoeboid state as part of the epithelial-to-mesenchymal transition programme","volume":"32","author":"Graziani","year":"2022","journal-title":"Trends Cell Biol."},{"key":"2026052905305082300_JCS264674C33","doi-asserted-by":"publisher","first-page":"115939","DOI":"10.1016\/j.celrep.2025.115939","article-title":"SLC7A11 protects amoeboid-disseminating cancer cells from oxidative stress","volume":"44","author":"Graziani","year":"2025","journal-title":"Cell Rep."},{"key":"2026052905305082300_JCS264674C34","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.2147\/DDDT.S86621","article-title":"Clinical development of galunisertib (Ly2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"2026052905305082300_JCS264674C35","doi-asserted-by":"publisher","first-page":"djv289","DOI":"10.1093\/jnci\/djv289","article-title":"Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination","volume":"108","author":"Herraiz","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"2026052905305082300_JCS264674C36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3171\/jns.1993.78.6.0944","article-title":"The effect of transforming growth factor-\u03b22-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma","volume":"78","author":"Jachimczak","year":"1993","journal-title":"J. Neurosurg."},{"key":"2026052905305082300_JCS264674C37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41556-022-01042-3","article-title":"LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion","volume":"25","author":"Jung-Garcia","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"2026052905305082300_JCS264674C38","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.cub.2025.02.066","article-title":"The activation of INF2 by Piezo1\/Ca2+ is required for mesenchymal-to-amoeboid transition in confined environments","volume":"35","author":"Kar","year":"2025","journal-title":"Curr. Biol."},{"key":"2026052905305082300_JCS264674C39","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1016\/j.cell.2025.05.019","article-title":"MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma","volume":"188","author":"Kenchappa","year":"2025","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C40","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1021\/acsbiomaterials.9b00519","article-title":"Breast cancer cells transition from mesenchymal to amoeboid migration in tunable three-dimensional silk-collagen hydrogels","volume":"5","author":"Khoo","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"2026052905305082300_JCS264674C41","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/onc.2009.515","article-title":"Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC","volume":"29","author":"Kitzing","year":"2010","journal-title":"Oncogene"},{"key":"2026052905305082300_JCS264674C42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1478-811X-11-51","article-title":"Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho\/ROCK\/MLC signaling","volume":"11","author":"Kosla","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"2026052905305082300_JCS264674C43","doi-asserted-by":"publisher","first-page":"2025.07.11.664494","DOI":"10.1101\/2025.07.11.664494","article-title":"Targeting cholesterol-dependent piezo1 activation impairs amoeboid migration in melanoma cells","author":"Kuang","year":"2025","journal-title":"bioRxiv"},{"key":"2026052905305082300_JCS264674C44","doi-asserted-by":"publisher","first-page":"e12203","DOI":"10.7554\/eLife.12203","article-title":"Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis","volume":"5","author":"K\u00fcmper","year":"2016","journal-title":"eLife"},{"key":"2026052905305082300_JCS264674C45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2026052905305082300_JCS264674C46","doi-asserted-by":"publisher","first-page":"11448","DOI":"10.1021\/acs.jmedchem.0c00525","article-title":"Discovery of AB680: a potent and selective inhibitor of CD73","volume":"63","author":"Lawson","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026052905305082300_JCS264674C47","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.joca.2024.08.009","article-title":"The cereblon-AMPK (AMP-activated protein kinase) axis in chondrocytes regulates the pathogenesis of osteoarthritis","volume":"32","author":"Lee","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"2026052905305082300_JCS264674C48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cub.2016.11.057","article-title":"Hypoxia induces a HIF-1-dependent transition from collective-to-amoeboid dissemination in epithelial cancer cells","volume":"27","author":"Lehmann","year":"2017","journal-title":"Curr. Biol."},{"key":"2026052905305082300_JCS264674C49","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2015.01.007","article-title":"Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells","volume":"160","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C50","doi-asserted-by":"publisher","first-page":"e08314","DOI":"10.7554\/eLife.08314","article-title":"Erk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration","volume":"4","author":"Logue","year":"2015","journal-title":"eLife"},{"key":"2026052905305082300_JCS264674C51","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-017-0071-5","article-title":"C-Src activity is differentially required by cancer cell motility modes","volume":"37","author":"Logue","year":"2018","journal-title":"Oncogene"},{"key":"2026052905305082300_JCS264674C52","doi-asserted-by":"publisher","first-page":"eaba2894","DOI":"10.1126\/science.aba2894","article-title":"The nucleus acts as a ruler tailoring cell responses to spatial constraints","volume":"370","author":"Lomakin","year":"2020","journal-title":"Science (1979)"},{"key":"2026052905305082300_JCS264674C53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2019.08.011","article-title":"Downregulation of epidermal growth factor receptor in hepatocellular carcinoma facilitates transforming growth factor-\u03b2-induced epithelial to amoeboid transition","volume":"464","author":"L\u00f3pez-Luque","year":"2019","journal-title":"Cancer Lett."},{"key":"2026052905305082300_JCS264674C54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41416-021-01442-6","article-title":"A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma","volume":"125","author":"Maiques","year":"2021","journal-title":"Br. J. Cancer"},{"key":"2026052905305082300_JCS264674C55","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-025-56299-7","article-title":"Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis","volume":"16","author":"Maiques","year":"2025","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C56","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1038\/s41467-024-51442-2","article-title":"The TGF\u03b2 type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed\/refractory multiple myeloma: a phase 1b trial","volume":"15","author":"Malek","year":"2024","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C57","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1158\/1078-0432.CCR-23-0276","article-title":"A phase Ib Trial of AVID200, a TGF\u03b2 1\/3 trap, in patients with myelofibrosis","volume":"29","author":"Mascarenhas","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"2026052905305082300_JCS264674C58","doi-asserted-by":"publisher","first-page":"112316","DOI":"10.1016\/j.ejmech.2020.112316","article-title":"Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors","volume":"197","author":"Matheson","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"2026052905305082300_JCS264674C59","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1242\/jcs.098343","article-title":"ERM proteins at a glance","volume":"127","author":"McClatchey","year":"2014","journal-title":"J. Cell Sci."},{"key":"2026052905305082300_JCS264674C99","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-20-0700","article-title":"First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors","volume":"26","author":"McLeod","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"2026052905305082300_JCS264674C60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/OARRR.S17118","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis","volume":"3","author":"Mihara","year":"2011","journal-title":"Open Access Rheumatol."},{"key":"2026052905305082300_JCS264674C61","doi-asserted-by":"publisher","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (Fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS ONE"},{"key":"2026052905305082300_JCS264674C62","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.bpj.2010.07.031","article-title":"Cell blebbing and membrane area homeostasis in spreading and retracting cells","volume":"99","author":"Norman","year":"2010","journal-title":"Biophys. J."},{"key":"2026052905305082300_JCS264674C63","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/ncomms5255","article-title":"Diverse matrix metalloproteinase functions regulate cancer amoeboid migration","volume":"5","author":"Orgaz","year":"2014","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2019.12.003","article-title":"Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance","volume":"37","author":"Orgaz","year":"2020","journal-title":"Cancer Cell"},{"key":"2026052905305082300_JCS264674C65","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/s41467-018-06134-z","article-title":"STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas","volume":"9","author":"Pan","year":"2018","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/1878-0261.12019","article-title":"Modes of invasion during tumour dissemination","volume":"11","author":"Pandya","year":"2017","journal-title":"Mol. Oncol."},{"key":"2026052905305082300_JCS264674C67","doi-asserted-by":"publisher","first-page":"115667","DOI":"10.1016\/j.biopha.2023.115667","article-title":"Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress","volume":"168","author":"Peyman","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"2026052905305082300_JCS264674C68","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-21-4176","article-title":"FDA approval summary: belumosudil for adult and pediatric patients 12 years and older with chronic GvHD after two or more prior lines of systemic therapy","volume":"28","author":"Przepiorka","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"2026052905305082300_JCS264674C69","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1016\/j.cell.2025.06.006","article-title":"Development of clinically viable non-muscle myosin II small molecule inhibitors","volume":"188","author":"Radnai","year":"2025","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-024-01019-5","article-title":"A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death","volume":"14","author":"Ray","year":"2024","journal-title":"Blood Cancer J."},{"key":"2026052905305082300_JCS264674C71","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41586-019-1087-5","article-title":"Nuclear positioning facilitates amoeboid migration along the path of least resistance","volume":"568","author":"Renkawitz","year":"2019","journal-title":"Nature"},{"key":"2026052905305082300_JCS264674C72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ceb.2015.08.005","article-title":"Rho GTPase signalling in cell migration","volume":"36","author":"Ridley","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"2026052905305082300_JCS264674C73","doi-asserted-by":"publisher","first-page":"e201912515","DOI":"10.1085\/jgp.201912515","article-title":"Disruption of membrane cholesterol organization impairs the activity of PIEZO1 channel clusters","volume":"152","author":"Ridone","year":"2020","journal-title":"J. Gen. Physiol."},{"key":"2026052905305082300_JCS264674C74","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1158\/0008-5472.CAN-12-0861","article-title":"AMPK activation by oncogenesis is required to maintain cancer cell proliferation in astrocytic tumors","volume":"73","author":"R\u00edos","year":"2013","journal-title":"Cancer Res."},{"key":"2026052905305082300_JCS264674C75","doi-asserted-by":"publisher","first-page":"783","DOI":"10.12688\/f1000research.7909.1","article-title":"Rho, ROCK and actomyosin contractility in metastasis as drug targets","volume":"5","author":"Rodriguez-Hernandez","year":"2016","journal-title":"F1000Res."},{"key":"2026052905305082300_JCS264674C76","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1038\/s41467-020-18951-2","article-title":"WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion","volume":"11","author":"Rodriguez-Hernandez","year":"2020","journal-title":"Nat. Commun."},{"key":"2026052905305082300_JCS264674C77","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2015.01.008","article-title":"Cortical contractility triggers a stochastic switch to fast amoeboid cell motility","volume":"160","author":"Ruprecht","year":"2015","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C78","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1158\/0008-5472.CAN-14-2156","article-title":"Rho kinase inhibitors block melanoma cell migration and inhibit metastasis","volume":"75","author":"Sadok","year":"2015","journal-title":"Cancer Res."},{"key":"2026052905305082300_JCS264674C79","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ncb1019","article-title":"Differing modes of tumour cell invasion have distinct requirements for Rho\/ROCK signalling and extracellular proteolysis","volume":"5","author":"Sahai","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"2026052905305082300_JCS264674C80","doi-asserted-by":"publisher","first-page":"adi0244","DOI":"10.1126\/sciadv.adi0244","article-title":"CD73 controls Myosin II\u2013driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells","volume":"9","author":"Samain","year":"2023","journal-title":"Sci. Adv."},{"key":"2026052905305082300_JCS264674C81","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","article-title":"Rac activation and inactivation control plasticity of tumor cell movement","volume":"135","author":"Sanz-Moreno","year":"2008","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C82","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccr.2011.06.018","article-title":"ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma","volume":"20","author":"Sanz-Moreno","year":"2011","journal-title":"Cancer Cell"},{"key":"2026052905305082300_JCS264674C83","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.3390\/molecules28155678","article-title":"The anticancer effect of napabucasin (BBI608), a natural naphthoquinone","volume":"28","author":"Shao","year":"2023","journal-title":"Molecules"},{"key":"2026052905305082300_JCS264674C84","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026052905305082300_JCS264674C85","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.cell.2019.04.017","article-title":"Physical principles of membrane shape regulation by the glycocalyx","volume":"177","author":"Shurer","year":"2019","journal-title":"Cell"},{"key":"2026052905305082300_JCS264674C86","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cub.2021.11.040","article-title":"Calpain-2 regulates hypoxia\/HIF-induced plasticity toward amoeboid cancer cell migration and metastasis","volume":"32","author":"te Boekhorst","year":"2022","journal-title":"Curr. Biol."},{"key":"2026052905305082300_JCS264674C87","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ncb2775","article-title":"Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions","volume":"15","author":"Tozluo\u01e7lu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"2026052905305082300_JCS264674C88","doi-asserted-by":"publisher","first-page":"252","DOI":"10.18632\/oncoscience.450","article-title":"Re-thinking preclinical models of cancer metastasis","volume":"5","author":"Ullo","year":"2018","journal-title":"Oncoscience"},{"key":"2026052905305082300_JCS264674C89","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-19-1231","article-title":"PGC1a suppresses prostate cancer cell invasion through ERRA transcriptional control","volume":"79","author":"Valcarcel-Jimenez","year":"2019","journal-title":"Cancer Res."},{"key":"2026052905305082300_JCS264674C90","doi-asserted-by":"publisher","first-page":"eaba2644","DOI":"10.1126\/science.aba2644","article-title":"The nucleus measures shape changes for cellular proprioception to control dynamic cell behavior","volume":"370","author":"Venturini","year":"2020","journal-title":"Science (1979)"},{"key":"2026052905305082300_JCS264674C91","doi-asserted-by":"publisher","first-page":"eady8052","DOI":"10.1126\/sciadv.ady8052","article-title":"Cluster nanoarchitecture and structural diversity of PIEZO1 at rest and during activation in intact cells","volume":"11","author":"Verkest","year":"2025","journal-title":"Sci. Adv."},{"key":"2026052905305082300_JCS264674C92","doi-asserted-by":"publisher","first-page":"e1312044","DOI":"10.1080\/2162402X.2017.1312044","article-title":"Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases","volume":"6","author":"Vijayan","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026052905305082300_JCS264674C93","doi-asserted-by":"publisher","first-page":"e2417145122","DOI":"10.1073\/pnas.2417145122","article-title":"Loss of lipid asymmetry facilitates plasma membrane blebbing by decreasing membrane lipid packing","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026052905305082300_JCS264674C94","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-023-05758-6","article-title":"Blebs promote cell survival by assembling oncogenic signalling hubs","volume":"615","author":"Weems","year":"2023","journal-title":"Nature"},{"key":"2026052905305082300_JCS264674C95","doi-asserted-by":"publisher","first-page":"2026.01.05.697601","DOI":"10.64898\/2026.01.05.697601","article-title":"In vivo evidence for bleb-induced survival signaling in metastatic melanoma","author":"Weems","year":"2026","journal-title":"bioRxiv"},{"key":"2026052905305082300_JCS264674C96","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/1091581821998945","article-title":"Nonclinical development of SRK-181: an anti-latent TGF\u03b21 monoclonal antibody for the treatment of locally advanced or metastatic solid tumors","volume":"40","author":"Welsh","year":"2021","journal-title":"Int. J. Toxicol."},{"key":"2026052905305082300_JCS264674C97","doi-asserted-by":"publisher","first-page":"80046","DOI":"10.18632\/oncotarget.11098","article-title":"First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors","volume":"7","author":"Willemien Menke-van der Houven van Oordt","year":"2016","journal-title":"Oncotarget"},{"key":"2026052905305082300_JCS264674C98","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41580-019-0172-9","article-title":"Mechanisms of 3D cell migration","volume":"20","author":"Yamada","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Journal of Cell Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/jcs\/article-pdf\/doi\/10.1242\/jcs.264674\/3701383\/jcs264674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/jcs\/article-pdf\/doi\/10.1242\/jcs.264674\/3701383\/jcs264674.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:30:58Z","timestamp":1780047058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/jcs\/article\/139\/10\/jcs264674\/371842\/Amoeboid-cancer-cells-at-a-glance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,15]]}},"URL":"https:\/\/doi.org\/10.1242\/jcs.264674","relation":{},"ISSN":["0021-9533","1477-9137"],"issn-type":[{"value":"0021-9533","type":"print"},{"value":"1477-9137","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"jcs264674"}}